Effective dose of IV dexmedetomidine for prolonging the duration of analgesia after single shot interscalene brachial plexus block with ropivacaine for shoulder surgery
Not Applicable
Completed
- Conditions
- Diseases of the musculo-skeletal system and connective tissue
- Registration Number
- KCT0002119
- Lead Sponsor
- Samsung Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 72
Inclusion Criteria
Patients who performed a unilateral shoulder surgery under general anesthesia with interscalene brachial plexus block
-ASA physical status I,II,III
-Age>18years, adult
Exclusion Criteria
-ASA IV or V patients
-Age<18years or pediatric patients
- pregnancy
- patients who have coagulopathy
- unstable coronary artery disease, congestive heart failure, arrythmia, cardiomyopathy
- patients who known cerebrovascular disease
- generalized infection, interscalene brachial plexus block site infection
- chronic pain disorder
- severe pulmonary disease
- known neurologic deficits, neuropathy affecting the brachial plexus
- refuse
- Allergy to clinical trial drug
- past medical history of psychiatric disease
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Duration of interscalene nerve block
- Secondary Outcome Measures
Name Time Method duration of motor blockade;opioid consumption;pain score;side effects to dexmedetomidine(bradycardia, temporary hypotension, sedation)